Cowealth Medical China Co.,Ltd. (SHA:603122)
China
· Delayed Price · Currency is CNY 15.25
-0.30 (-1.93%)
At close: Apr 29, 2026
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 6.19 billion as of April 29, 2026. Its market cap has increased by 119.32% in one year.
Market Cap
6.19B
Enterprise Value
6.17B
Revenue
656.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.25
Market Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 6.19B, an increase of 157.88%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.19B | -36.27% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maccura Biotechnology Co.Ltd | 6.31B |
| Beijing Strong Biotechnologies,Inc. | 7.20B |
| Amoy Diagnostics | 8.03B |
| Shanghai Runda Medical Technology | 8.18B |
| SMO ClinPlus CO.,LTD. | 4.51B |
| Thalys Medical Technology Group | 4.48B |
| Shanghai Labway Clinical Laboratory | 3.78B |
| Guangdong Hybribio Biotech | 3.72B |